Peripheral Artery Disease

Avinger Releases Wildcat Chronic Total Occlusion Crossing Results from the CONNECT Trial at EuroPCR Conference

Published in Medical Imaging Business Week, June 2nd, 2011

2011 JUN 2 -- Avinger, Inc. released initial data from the CONNECT Study today at the EuroPCR Conference in Paris. The study evaluated the safety and efficacy of the Wildcat Catheter in crossing chronic total occlusions (CTOs) in femoropopliteal lesions, the leading cause of amputation for patients suffering from peripheral artery disease (PAD).

The CONNECT Study (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) was a prospective, multi-center, non-randomized, U.S. IDE study conducted at 15 centers to support an expanded indication for crossing CTOs for Avinger's commercially available Wildcat Catheter. Results showed both the primary safety and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Business Week

Source: Medical Imaging Business Week (2011-06-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry